✨ Medicines Consent Notices
3 FEBRUARY 2005 NEW ZEALAND GAZETTE, No. 32
765
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Copegus
Ribavirin 200mg
Film coated tablet
Roche Products (New Zealand) Limited
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Patheon Inc, Mississauga, Ontario, Canada
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Paroxetine 20 mg
Paroxetine mesilate 25.83mg equivalent to 20mg paroxetine base
Film coated tablet
AFT Pharmaceuticals Limited
Heumann PCS GmbH, Feucht, Germany
Synthon Hispania SL, Sant Boi de Llobregat, Barcelona, Spain
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Pegasys (notification received 28 July 2004)
Peginterferon alfa-2a 270µg/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Pegasys (notification received 28 July 2004)
Peginterferon alfa-2a 360µg/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Pegasys (notification received 29 July 2004)
Peginterferon alfa-2a 270µg/mL
Solution for injection
Roche Products (New Zealand) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland
Product:
Pegasys (notification received 29 July 2004)
Active Ingredient:
Peginterferon alfa-2a 360µg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche Limited, Basel, Switzerland
Dated this 29th day of January 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go587
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
AQuify
Sodium hyaluronate 1g/L
Eye drops, solution
Ciba Vision Australia Pty Limited
Ciba Vision Canada Inc, Mississauga, Ontario, Canada
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Complete Moisture Plus Multi-Purpose Solution
Hypromellose 0.15%w/v
Propylene glycol 0.5%w/v
Contact lens solution
Advanced Medical Optics Australia Pty Limited
AMO (Hangzhou) Co Limited, Hangzhou, Zhejiang, China
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Fluconazole
Fluconazole 100mg
Capsule
Pacific Pharmaceuticals Limited
Genpharm Inc., Etobicoke, Ontario, Canada
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 32
Gazette.govt.nz —
NZ Gazette 2005, No 32
✨ LLM interpretation of page content
🏥 Consent to Distribution of Changed Medicines
🏥 Health & Social Welfare29 January 2005
Medicines Act, Consent, Distribution, Pharmaceuticals
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines Act, Consent, Distribution, New Medicines